Transdermal Therapeutics, Inc.
Quick facts
Marketed products
- A/B
A/B is a transdermal delivery system designed to provide controlled release of an active pharmaceutical ingredient through the skin.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: